Indiana Regional Medical Center has announced that they are the first to use a new treatment technique that they have been working on with a local research company concerning stem cells.
IRMC announced that on September 12th, orthopedic surgeon Brandon Trale performed a reduction of a hip fracture aided with the introduction of placental-derived stem cells to help rebuild muscle tissue for a quicker recovery time. This marks the first time the procedure has ever been performed in the United States.
The patient, identified only as an 83-year-old retired Math teacher from the Penns Manor School District consented to the clinical trial of this procedure, and is “recovering well” according to IRMC. The procedure was to help with a femoral (FEM-or-al) neck fracture, which is the most common form of hip fracture. The operation was performed using a phase 3 study working with local research company Antria. This study is one of several being done across the United States for a large pharmaceutical company in Israel, with IRMC being the only non-academic site selected.
Dr. Brian Hawthorne said in the news release that he was proud the hospital was able to take part in the landmark trial.
